Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats.
S Stevens Negus, Robert O'Connell, Ember Morrissey, Kejun Cheng, Kenner C Rice
文献索引:J. Pharmacol. Exp. Ther. 340(3) , 501-9, (2012)
全文:HTML全文
摘要
κ opioid receptor agonists that do not readily cross the blood-brain barrier are peripherally restricted and distribute poorly to the central nervous system after systemic administration. Peripherally restricted κ agonists have promise as candidate analgesics, because they may produce antinociception mediated by peripheral κ receptors more potently than they produce undesirable sedative and psychotomimetic effects mediated by central κ receptors. The present study used assays of pain-related stimulation and depression of behavior in rats to compare effects of 1) two peripherally restricted κ agonists [the tetrapeptide D-Phe-D-Phe-D-Ile-D-Arg-NH(2) (ffir) and the nonpeptidic compound ((R,S)-N-[2-(N-methyl-3,4-dichlorophenylacetamido)-2-(3-carboxyphenyl)-ethyl]pyrrolidine hydrochloride (ICI204448)], 2) a centrally penetrating κ agonist (salvinorin A), and 3) several reference drugs, including a nonsteroidal anti-inflammatory drug (NSAID; ketoprofen). Intraperitoneal injection of dilute lactic acid served as a noxious stimulus to stimulate a stretching response and depress intracranial self-stimulation (ICSS) maintained by the delivery of electrical brain stimulation to the medial forebrain bundle. Acid-stimulated stretching was blocked by ketoprofen, the peripherally restricted κ agonists, and salvinorin A. However, acid-induced depression of ICSS was blocked only by ketoprofen. The peripherally restricted κ agonists had little effect, and salvinorin A exacerbated acid-induced depression of ICSS. These results suggest that peripherally restricted κ agonists may be safer than centrally penetrating κ agonists but less efficacious than NSAIDS or μ opioid receptor agonists to block pain-related depression of behavior; however, the peripheral selectivity of ffir and ICI204448 is limited, and future studies with κ agonists capable of greater peripheral selectivity are warranted.
相关化合物
相关文献:
2014-07-01
[J. Pharmacol. Exp. Ther. 350(1) , 69-78, (2014)]
2012-11-01
[Int. J. Drug Policy 23(6) , 512-21, (2012)]
2013-09-27
[J. Nat. Prod. 76(9) , 1654-60, (2013)]
2012-01-15
[Bioorg. Med. Chem. Lett. 22(2) , 1023-6, (2012)]
2013-03-01
[Bioanalysis 5(6) , 661-8, (2013)]